Companies: 10,795·Total market cap: $144.5T
LexaGene Holdings Inc.

LexaGene Holdings Inc.

LXXGFOTCHealthcare
$0.08
+$0.00(+0.00%)
Market Cap$11335745
P/E Ratio
52W High$0.2213
52W Low$0.04963

LexaGene Holdings Inc.(LXXGF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · LXXGF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-022021-022020-022019-022018-02
Revenue
Revenue$0.08M$0.06M$0.00M$0.00M$0.00M
Cost of Revenue$0.54M$0.16M$0.00M$0.00M$0.00M
Gross Profit($0.47M)($0.10M)$0.00M$0.00M$0.00M
Gross Margin %(computed)-621.40%-173.76%
Operating Expenses
R&D Expenses$5.88M$5.81M$4.46M$5.38M$1.67M
G&A Expenses$3.02M$2.83M$1.31M$1.57M$1.73M
Total Operating Expenses$10.10M$9.71M$7.40M$8.32M$3.98M
Operating Income($10.64M)($9.82M)($7.40M)($8.32M)($3.95M)
Operating Margin %(computed)
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$0.07M$0.07M$0.10M$0.00M$0.00M
Income Before Tax($10.62M)($9.89M)($7.50M)($8.32M)($4.00M)
Income Tax Expense($0.02M)$0.07M$0.10M($0.00M)$0.03M
Net Income($10.62M)($9.97M)($7.60M)($8.32M)($4.03M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-0.09$-0.10$-0.10$-0.13$-0.08
Wtd Avg Shares119.98M103.62M76.39M63.76M52.49M
EBITDA($10.05M)($9.29M)($6.89M)($8.19M)($3.93M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解LexaGene Holdings Inc.

关于LexaGene Holdings Inc.(LXXGF)损益表

LexaGene Holdings Inc.(LXXGF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,LXXGF实现营收$0.00B,毛利润($0.00B)(毛利率-621.40%),净利润($0.01B)(净利率-14100.96%)。

常见问题

LXXGF · 4 问

LexaGene Holdings Inc.(LXXGF)2022财年营收为$0.00B,同比up29.6%。

LXXGF revenueLXXGF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09